Ultrasound-assisted, Catheter-directed Thrombolysis for Acute Intermediate-high-risk Pulmonary Embolism
Condition(s) studied
Investigational drug(s) / intervention(s)
ultrasound-assisted, catheter-directed thrombolysis: After 10 hours of alteplase infusion and EKOSTM ultrasound, the therapy is stopped, the EKOSTM catheter is removed, and the puncture site (internal jugular vein or femoral vein) has to be compressed.
Study summary
The purpose of this retrospective and prospective multicenter study is to evaluate the incidence of pulmonary hypertension (PH) within 6 months from ultrasound-assisted, Catheter-directed Thrombolysis for acute intermediate- high-risk Pulmonary Embolism
Eligibility
Primary outcome measure(s)
- development of pulmonary hypertension — 6 months from treatment
number of cases
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| ASST GOM Niguarda | Milan | Italia | Recruiting |
More Niguarda Hospital trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06143969 on ClinicalTrials.gov ↗ ← All trials in Italy